-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EHEHncpoSUNeGV9+gsp+rzSUoKcZ6sNJXtnD8ggfTpDXMqFXjV0BWyb/qmanwq/D MLRtxXzq85KMVP0fW+MmrA== 0000040417-96-000004.txt : 19960207 0000040417-96-000004.hdr.sgml : 19960207 ACCESSION NUMBER: 0000040417-96-000004 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960313 FILED AS OF DATE: 19960206 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENERAL AMERICAN INVESTORS CO INC CENTRAL INDEX KEY: 0000040417 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 13509845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 811-00041 FILM NUMBER: 96511547 BUSINESS ADDRESS: STREET 1: 450 LEXINGTON AVENUE STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2129168400 MAIL ADDRESS: STREET 1: 450 LEXINGTON AVENUE STREET 2: SUITE 3300 CITY: NEW YORK STATE: NY ZIP: 10017 DEF 14A 1 PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ___) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) [X] Definitive Proxy Statement [ ] Definitive Additional Materials [ ] Soliciting Material Pursuant to section 240.14a-11(c) or section 240.14a-12 General American Investors Company, Inc. (Name of Registrant as Specified in its Charter) [Insert Name] (Name of Person(s) Filing Proxy Statement if other than the Registrant) Payment of Filing Fee (Check the appropriate box): [X] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i), or 14a-6(i)(2) or Item 22(a)(2) of Schedule 14A. [ ] $500 per each party to the controversy pursuant to Exchange Act Rule 14a-6(i)(3). [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which registrant applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: [ ] Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: GENERAL AMERICAN INVESTORS Company, Inc. 450 Lexington Avenue . New York . N.Y. 10017 Notice of Annual Meeting of Stockholders February 5, 1996 To the Stockholders of GENERAL AMERICAN INVESTORS Company, Inc. NOTICE IS HEREBY GIVEN that the annual meeting of stockholders of General American Investors Company, Inc. will be held in the Presidents Room on the Third Floor of the Harvard Club of New York City, 27 West 44th Street, New York City, N.Y., on Wednesday, March 13, 1996 at 2:30 o'clock in the afternoon, New York Time, for the purpose of (a) Electing directors to hold office until the annual meeting of stockholders next ensuing after their election and until their respective successors are elected and shall have qualified; and (b) Ratifying or rejecting the selection by the Board of Directors of the Company of the firm of Ernst & Young LLP to be the auditors of the Company for the year ending December 31, 1996; and (c) Approving or rejecting the shareholder proposal recommending that the Board of Directors convert the Company into an open- end investment company; and (d) Transacting any and all such other business as may properly come before the meeting or any adjournment or adjournments thereof in connecting with the foregoing or otherwise. The minute books of the Company, containing the minutes of all meetings of the Board of Directors since the last annual meeting of the stockholders, will be presented to the meeting and will there be open to the inspection of the stockholders. The close of business on January 22, 1996 has been fixed as the record date for the determination of the stockholders entitled to notice of, and to vote at, the meeting. This notice and related proxy material is expected to be mailed on or about February 5, 1996. By Order of the Board of Directors, Carole Anne Clementi Secretary If you do not expect to attend the meeting in person and wish your stock to be voted, you are requested to fill in and sign the accompanying form of proxy and return it in the accompanying envelope. GENERAL AMERICAN INVESTORS Company, Inc. 450 Lexington Avenue . New York . N.Y. 10017 PROXY STATEMENT February 5, 1996 This statement is furnished in connection with the solicitation by the Board of Directors of General American Investors Company, Inc. (hereinafter called the "Company" or the "Corporation") of proxies to be used at the annual meeting of stockholders of the Company, to be held in the Presidents Room on the Third Floor of the Harvard Club of New York City, 27 West 44th Street, New York City, N.Y., on Wednesday, March 13, 1996 at 2:30 o'clock in the afternoon (and at any adjournment or adjournments thereof) for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. Stockholders who execute proxies retain the right to revoke them at any time insofar as they have not been exercised, by written notice to the Secretary of the Company or by attendance at the Annual Meeting. The close of business on January 22, 1996 has been fixed as the record date for the determination of the stockholders entitled to notice of, and to vote at, the meeting. This proxy statement and the form of proxy are expected to be mailed on or about February 5, 1996. Proxies returned will be voted in accordance with the instructions thereon or, if no instructions are indicated, in favor of the directors named herein, to approve the appointment of Ernst & Young LLP as auditors and against the shareholder proposal relating to the conversion of the Company into an open-end investment company. As of January 22, 1996, the Company had outstanding 23,901,016 shares of Common Stock, $1 par value, each share carrying one vote. A. Respecting the Election of Directors At the meeting, fourteen directors are to be elected to hold office until the annual meeting of stockholders next ensuing after their election and until their respective successors are elected and shall have qualified. It is the intention of the persons named in the accompanying form of proxy to nominate and to vote such proxy for the election of persons named below or, if any such persons should be unable to serve, for the election of such other person or persons as shall be determined by the persons named in the proxy in accordance with their judgment. All of the persons named below, except for Ms. Victoria Hamilton, are incumbent directors. They have agreed to serve if elected.
COMMON STOCK, SHARES NAME AND BUSINESS ADDRESS PRINCIPAL OCCUPATION*, BUSINESS EXPERIENCE BECAME BENEFICIALLY OWNED PERCENT DURING PAST FIVE YEARS AND AGE DIRECTOR DEC. 31, 1995 ** OF CLASS - ------------------------------------------------------------------------------------------------------------------------------------ Arthur G. Altschul, Jr. Mr. Altschul has been Senior Director, Corporate 1995 95,351 .40 SUGEN, Inc. (biopharmaceuticals) Affairs of SUGEN, Inc. since January 1996; prior 515 Galveston Drive thereto, he was Director of Corporate Affairs Redwood City, CA 94063 (May 1995 to January 1996), Director of Strategic Planning (May 1992 to May 1995) and Manager of Finance and Investor Relations (January 1992 to May 1992). He has been Assistant Secretary of SUGEN since May 1992. Prior to joining SUGEN, Mr. Altschul was a research assistant with Morgan Stanley & Co., Inc., New York, NY from September 1990. Mr. Altschul has been managing general partner of Altschul Investment Group, L.P. (a private investment partnership), New York, NY since 1988. He is a director of Medicis Pharmaceutical Corporation, Phoenix, AZ. Mr. Altschul is 31 years old.
1 (continued on page 2)
COMMON STOCK, SHARES NAME AND BUSINESS ADDRESS PRINCIPAL OCCUPATION*, BUSINESS EXPERIENCE BECAME BENEFICIALLY OWNED PERCENT DURING PAST FIVE YEARS AND AGE DIRECTOR DEC. 31, 1995 ** OF CLASS - ------------------------------------------------------------------------------------------------------------------------------------ Lawrence B. Buttenwieser Mr. Buttenwieser has been a Partner of Rosenman 1967 663,753 2.78 Rosenman & Colin & Colin and predecessor firms since 1966. He (lawyers) has been the Chairman of the Board of Directors 575 Madison Avenue of the Company since May 1995 and a director New York, NY 10022 of the Company since 1967. He is also a director of Time Warner Inc., New York, NY. Mr. Buttenwieser is 64 years old. Lewis B. Cullman Mr. Cullman has been president of Cullman 1961 91,822 .38 Cullman Ventures, Inc. Ventures, Inc. (formerly solely a holding (calendars and catalogs) company) since 1968. He is chairman and a 767 Third Avenue director of the American Chess Foundation New York, NY 10017 (charitable foundation), New York, NY. Mr. Cullman is vice chairman of the international council and an honorary trustee of the Museum of Modern Art, New York, NY. Mr.Cullman is 77 years old. Spencer Davidson # Mr. Davidson has been President and Chief Executive 1995 168,778 .71 General American Investors Officer of the Company since August 1995; prior Company, Inc. thereto he was senior investment counsellor since 450 Lexington Avenue joining the Company in 1994. He was elected a New York, NY 10017 Director of the Company in September 1995. Before joining General American, Mr. Davidson was the General Partner of The Hudson Partnership (a private investment partnership), New York, NY. He is a trustee of the Neurosciences Research Foundation (scientific research foundation), San Diego, CA. Mr. Davidson is 53 years old. Gerald M. Edelman Dr. Edelman has been a member and the chairman 1976 954 .00 Member and Chairman of the of the Department of Neurobiology of The Scripps Department of Neurobiology Research Institute since July 1992; prior thereto, The Scripps Research Institute he was Vincent Astor Professor of The Rockefeller 10666 North Torrey Pines Rd. University, New York, NY. Dr. Edelman is director La Jolla, CA 92037 and president of the Neurosciences Institute of the Neurosciences Research Foundation (scientific research foundation), San Diego, CA; president and a director of the Neurosciences Support Corporation (scientific research support foundation), San Diego, CA; a director of Becton, Dickinson and Company, Franklin Lakes, NJ; and a member emeritus of the board of governors of the Weizmann Institute of Science, Rehovot, Israel. Dr. Edelman is 66 years old. Anthony M. Frank Mr. Frank has been Chairman of Belvedere Partners 1992 3,615 .02 Chairman and Director since 1994. He has been Chairman of Acrogen Inc. Belvedere Partners (biotechnology company), Oakland, CA since March (private financial consulting) 1992; prior thereto, he was The Postmaster 1 Maritime Plaza, Suite 1201 General of the United States from March 1988. San Francisco, CA 94111 Prior to entering government service, he was chairman of First Nationwide Bank. Mr. Frank is a director of Bedford Properties, Lafayette, CA; Crescent Real Estate Equities, Inc., New York, NY; Financial Security Assurance Holdings Ltd., New York, NY; Irvine Apartment Communities, Inc., Newport Beach, CA; Living Centers of America, Houston, TX; The Schwab (Charles) Corporation, San Francisco, CA and Temple-Inland Inc., Diboll, TX. He is a director and consultant of Transamerica Home First Inc., San Francisco, CA and an overseer of the Amos Tuck School of Business, Dartmouth College, Hanover, NH. Mr. Frank is 64 years old.
2 (continued on page 3)
COMMON STOCK, SHARES NAME AND BUSINESS ADDRESS PRINCIPAL OCCUPATION*, BUSINESS EXPERIENCE BECAME BENEFICIALLY OWNED PERCENT DURING PAST FIVE YEARS AND AGE DIRECTOR DEC. 31, 1995 ** OF CLASS - ------------------------------------------------------------------------------------------------------------------------------------ John D. Gordan, III Mr. Gordan has been a partner of Morgan, Lewis 1986 4,971 .02 Morgan, Lewis and Bockius and Bockius since October 1994; prior thereto, (lawyers) he was a partner of Lord Day & Lord, Barrett 101 Park Avenue Smith and predecessor firm from 1979. New York, NY 10178 Mr. Gordan is 50 years old. Bill Green Mr. Green represented the 15th New York 1993 2,310 .01 Corporate director and Congressional District (east side of Manhattan) trustee in the U.S. House of Representatives from 1978 14 E. 60th Street - Suite 702 through 1992. He is a director of ClientSoft, New York, NY 10022 Inc., Tarrytown, NY; Energy Answers Corporation, Albany, NY; and Washington Forecast, Inc., Washington, DC. He is also a member of the New York City Campaign Finance Board, New York, NY and a member and vice chair of the New York City Housing Development Corporation, New York, NY. Mr. Green is 66 years old. Victoria Hamilton # Ms. Hamilton, has been Executive Vice-President -- 500 .00 General American Investors and Chief Operating Officer of the Company since Company, Inc. August 1995; prior thereto, she was a Vice- 450 Lexington Avenue President from the time she joined the Company New York, NY 10017 in February 1992. Before joining General American, she was a principal with SRK Management Company (a private investment company), New York, NY from 1982. Ms. Hamilton is a director of Microbiological Associates, Inc., Rockville, MD. Ms. Hamilton is 42 years old. Sidney R. Knafel Mr. Knafel has been managing partner of SRK 1994 12,772 .05 Managing Partner Management Company since 1981. He is chairman SRK Management Company of the board of directors of Insight (private investment company) Communications, Inc., New York, NY; and 126 East 56th Street Microbiological Associates, Inc., Rockville, MD. New York, NY 10022 Mr. Knafel is a director of Cellular Communications, Inc., New York, NY; Cellular Communications International, Inc., New York, NY; Cellular Communications of Puerto Rico, Inc., New York, NY; IGENE Biotechnology, Inc., Columbia, MD; International CableTel, Inc., New York, NY; four mutual funds: Prudential Global Fund, Inc., Prudential Short-Term Global Income Fund, Inc., Prudential Pacific Growth Fund, Inc., and Prudential U.S. Government Fund, all located in New York, NY; and several privately owned companies. Mr. Knafel is 65 years old. Richard R. Pivirotto Mr. Pivirotto was chairman of the board of 1971 965 .00 President, Richard R. Pivirotto directors of Associated Dry Goods Corporation, Co., Inc. New York, NY from 1976 until his retirement in (self-employed consultant) 1981. He is a director of The Gillette Company, 111 Clapboard Ridge Road Boston, MA; Immunomedics, Inc. (biopharmaceuticals), Greenwich, CT 06830 Morris Plains, NJ; New York Life Insurance Company, New York, NY; and Westinghouse Electric Corporation, Pittsburgh, PA. He is a trustee of Greenwich Hospital Corporation, Greenwich, CT, a trustee of the General Theological Seminary, New York, NY, and a charter trustee emeritus of Princeton University, Princeton, NJ. Mr. Pivirotto is 65 years old.
3 (continued on page 4)
COMMON STOCK, SHARES NAME AND BUSINESS ADDRESS PRINCIPAL OCCUPATION*, BUSINESS EXPERIENCE BECAME BENEFICIALLY OWNED PERCENT DURING PAST FIVE YEARS AND AGE DIRECTOR DEC. 31, 1995 ** OF CLASS - ------------------------------------------------------------------------------------------------------------------------------------ Malcolm B. Smith # Mr. Smith has been Vice-Chairman of the Board 1960 72,414 .30 General American Investors of Directors of the Company since March 1989; Company, Inc. prior thereto, he was President from 1961. Mr. 450 Lexington Avenue Smith served as Interim Chief Executive Officer New York, NY 10017 of the Company from June to August 1995. Mr. Smith is a director of Cybersmith, Inc. (educational retail stores), Cambridge, MA; and the Human Rights Watch (non-profit human rights organization), New York, NY. He is a trustee of the New School for Social Research, New York, NY; and a trustee of the New York Foundation (philanthropic foundation), New York, NY. Mr. Smith is 72 year old. Joseph T. Stewart, Jr. Mr. Stewart has been an executive consultant 1987 11,040 .05 147 Rolling Hill Road to Johnson & Johnson, New Brunswick, NJ since Skillman, NJ 08558 September 1990; prior thereto, he was a consultant to Bristol-Myers Squibb Company from January 1990 to March 1990. Mr. Stewart was senior vice president, corporate affairs of Squibb Corporation from 1982 until he retired in January 1990. He was a director of Squibb Corporation from 1984 until its merger into Bristol-Myers Squibb Company in 1989. He is a director of Liposome Co., Inc., Princeton, NJ, a trustee of the Foundation of the University of Medicine and Dentistry of New Jersey, Newark, NJ, a trustee of the New School for Social Research, New York, NY, and a member of the advisory council to the Marine Biological Laboratory, Woods Hole, MA. Mr. Stewart is 66 years old. Raymond S. Troubh Mr. Troubh has been a financial consultant 1989 13,695 .06 10 Rockefeller Plaza, Suite 712 since 1974. He is a director of ADT Limited, New York, NY 10020 Boca Raton, FL; America West Airlines, Inc., Phoenix, AZ; Applied Power Inc., Brookfield, WI; Ariad Pharmaceuticals, Inc., Cambridge, MA; Becton, Dickinson and Company, Franklin Lakes, NJ; Benson Eyecare Corporation, Rye, NY; Diamond Offshore Drilling, Inc., Houston, TX; Foundation Health Corporation, Rancho Cordova, CA; Manville Corporation, Denver, CO; Olsten Corporation, Westbury, NY; Petrie Stores Corporation, Secaucus, NJ; Riverwood International Corporation, Atlanta, GA; Time Warner Inc., New York, NY; Triarc Companies, Inc., New York, NY; and WHX Corporation, New York, NY. Mr. Troubh is 69 years old. * If the principal occupation shown has been held for less than five years, additional background information relating to the director's principal occupation is included in the supplemental paragraph together with his other directorships. ** This information has been furnished by each director. In addition to shares owned beneficially, shares as to which directors have or share the power to vote or dispose are as follows:
NAME Shares Percent of Class - ---- ------ ---------------- Lewis B. Cullman 45,127 .19 John D. Gordan, III 310,273 1.30
# Mr. Davidson and Ms. Hamilton are "interested persons" of the Company, as defined under Section 2a(19) of the Investment Company Act of 1940, as amended, by reason of their being officers of the Company. Mr. Smith is an "interested person" of the Company by reason of his being an officer of the Board of Directors of the Company and maintaining an office at the Company. 4 The directors and officers as a group owned beneficially or have or share the power to vote or dispose of an aggregate 1,531,777 shares of Common Stock (6.41% of the class). In addition, the Company has the power to vote 464,359 shares of Common Stock (1.94% of the class) held by the trustee for the Company's Employees' Thrift Plan, as described below. Meetings of Committees of the Board of Directors During 1995, the Company's Board of Directors held twelve meetings. The Audit Committee of the Board of Directors consists of the following directors, all of whom are "non- interested" directors: Mr. John D. Gordan, III, Chairman, Mr. Arthur G. Altschul, Jr., Mr. Lawrence B. Buttenwieser, Mr. Lewis B. Cullman, Mr. Bill Green, Mr. Sidney R. Knafel and Mr. Raymond S. Troubh; and Dr. William O. Baker and Mr. Anthony M. Frank, alternates. Generally, for the Company, the Audit Committee monitors financial reporting, reviews reports on the system of internal accounting control, reviews the scope of the audit work, reviews fees in relation to services performed by the auditors, reviews the results of auditors' work, reviews and oversees responses to recommendations, if any, made to the Company by the auditors, recommends the selection of the auditors to the Board of Directors and acts as a liaison between the Board of Directors and the auditors and management personnel. The Committee met four times during the fiscal year, on January 11, April 12, September 13 and December 13, 1995. The Compensation Committee of the Board of Directors consists of the following directors: Mr. Bill Green, Chairman, Dr. William O. Baker, Mr. Lawrence B. Buttenwieser, Mr. Anthony M. Frank, Mr. William T. Golden, Mr. Sidney R. Knafel, Mr. Richard R. Pivirotto, Mr. Malcolm B. Smith, Mr. Joseph T. Stewart, Jr. and Mr. Raymond S. Troubh; and Mr. Lewis B. Cullman and Dr. Gerald M. Edelman, alternates. Generally, for the Company, the Compensation Committee reviews the operations of the Company and performance and contributions made during each year by its officers and employees, reviews management proposals for year-end supplemental compensation and levels of compensation for the ensuing year, reviews comparable operating and compensation data of other companies in the investment industry, employs the services of an independent compensation consultant and makes recommendations on matters of compensation to the Board of Directors. The Committee met once during the fiscal year, on November 1, 1995. The Executive Committee/Nominating Committee of the Board of Directors consists of the following Directors: Mr. Richard R. Pivirotto, Chairman, Mr. Lawrence B. Buttenwieser, Mr. Spencer Davidson, Dr. Gerald M. Edelman, Mr. William T. Golden, Mr. Harold J. Kingsberg, Mr. Malcolm B. Smith and Mr. Joseph T. Stewart, Jr.; and Mr. John D. Gordan, III, and Mr. Bill Green, alternates. In addition to functioning as an Executive Committee with authority to exercise the powers of the Board of Directors in the management of the business and affairs of the Company when the Board is not in session, the Executive Committee/Nominating Committee is responsible for identifying individuals who may be nominated to serve as Directors of the Company, responding to inquiries relating to nominations to the Board and making recommendations to the Board with respect to individuals to be nominated to serve as Directors. The Committee met three times during the fiscal year, on February 8, May 1 and December 13, 1995. Each Director attended at least seventy-five percent of the aggregate number of meetings of the Board of Directors and of the committee(s) on which he serves. Executive Officers In addition to Mr. Spencer Davidson, President and Chief Executive Officer of the Company, and Ms. Victoria Hamilton, Executive Vice-President and Chief Operating Officer, information with respect to whom is set forth above, the executive officers of the Company include the following. (Officers are elected each year by the Board of Directors at its annual organization meeting in March.) Mr. S. Lawrence Feit, 51, Senior Vice President since January 1991 and, prior thereto, Vice-President from January 1986, has been a security analyst with the Company since March 1985. He is principally responsible for securities in the consumer goods and services, medical, paper, and transportation industries. 5 Mr. John J. Smith, 45, Vice-President since January 1989 and, prior thereto, Secretary from January 1986, has been a security analyst with the Company since March 1981. Mr. Smith is principally responsible for securities in the chemical, medical, and environmental control industries. Mr. Andrew V. Vindigni, 36, Vice-President since September 1995 and, prior thereto, Assistant Vice-President from January 1991, has been a security analyst with the Company since 1988. Mr. Vindigni is principally responsible for securities in the financial services industry. Mr. Eugene L. DeStaebler, Jr., 57, has been Vice-President, Administration since January 1978, and served as Treasurer (March 1985-December 1989). Mr. Peter P. Donnelly, 47, Vice-President since January 1991 and prior thereto, Assistant Vice-President from January 1984, has been the securities trader for the Company since 1974. Mrs. Diane G. Radosti, 43, Treasurer since January 1990, has been an employee of the Company since 1980. Mrs. Carole Anne Clementi, 49, Secretary since October 1994 and, prior thereto, Assistant Secretary from July 1993, has been an employee of the Company since 1982. Executive Compensation The following table sets forth the compensation received during 1995 from the Company (including compensation received from the Company's subsidiary, General American Advisers, Inc.) by its executive officers and directors.
Pension or Name of Individual Capacities retirement or number of persons in which Aggregate benefits accrued in group served Compensation during 1995 * - -------------------- ----------- ------------- ----------------- Spencer Davidson President and $ 367,460 $16,002 Chief Executive Officer Harold J. Kingsberg Executive Vice-President ** 390,000 46,800 S. Lawrence Feit Senior Vice-President 295,000 31,806 11 executive officers 2,925,352 262,374 as a group 16 directors as 269,000 *** a group * The amounts shown in this column represent the Company's payments made during 1995 to the trustee of the Company's Employees' Thrift Plan, as described below, or accounting reserves established during 1995 under the Company's Excess Contribution Plan, as described below, on behalf of the respective individuals or group members. ** Mr. Kingsberg retired as an officer and employee of the Company as of December 31, 1995. *** Each director who is not a paid officer of the Company received a fee of $10,000 as an annual retainer, a fee of $500 for attendance at each Directors' meeting, $500 for each Committee meeting which he attended in his capacity as a Director and $500 for attendance at each Company staff conference meeting.
With respect to the Company's Employees' Thrift Plan, the Company matches 150% of an employee's contributions up to 8% of basic salary to the plan. Company contributions are invested in shares of the Company's common stock. An employee's interest in Company contributions to his account is fully vested after six years of service. Partial vesting begins after two years of participation in the plan. All employees, including officers, are eligible to participate in the Thrift Plan after six months of services with the Company. Employees whose annual compensation exceeds $150,000 are required to invest their future contributions to the plan in shares of the Company's common stock, and their existing plan balances will be converted into the Company's common stock over the three years next succeeding the attainment of that compensation level. The Company has an Employees' Retirement Plan which is broadly characterized as a defined benefit plan. The Company contributes to the trustee for the plan annual costs which include actuarially determined current service costs and amortization of prior service costs. Retirement benefits are based on final average earnings (basic salary, exclusive of overtime, bonuses, commissions, pension, retainer fees, fees under contracts or any other forms of additional or special compensation, for the five consecutive years in which the participant had the highest basic salary during the last ten years of service) and years of credited service, 6 less an offset for social security covered compensation, plus an additional amount equal to $50 for each year of credited service. All employees, including officers, over age 21 commence participation in the plan after one year of service and are fully vested after six years of service. Partial vesting begins after two years of service. Participants are eligible to receive normal retirement benefits at age 65. In certain instances, a reduced benefit may begin upon retirement between ages 55 and 65. The following table shows the estimated annual retirement benefits (including amounts attributable to the Company's Excess Benefit Plan, as described below), which are subject to a deduction based on a portion of social security covered compensation, payable on a straight life annuity basis, at normal retirement date to all eligible employees, including officers, in specified compensation and years-of-service classifications:
Estimated Annual Benefits Based Upon Years of Credited Service ------------------------------------------------------------- Final Average 10 20 30 40 Earnings $ 50,000 $ 8,645 $ 17,290 $ 25,935 $ 31,865 100,000 16,790 33,580 50,370 61,730 150,000 24,935 49,870 74,805 91,595 200,000 33,080 66,160 99,240 121,460 250,000 41,225 82,450 123,675 151,325 300,000 49,370 98,740 148,110 181,190 350,000 57,515 115,030 172,545 211,055 400,000 65,660 131,320 196,980 240,920
For those officers of the Company listed in the compensation table on page 6, the following indicates his years of credited service in the Company's Retirement Plan and basic salary for 1995. Spencer Davidson (1) $297,000, Harold J. Kingsberg (32) $390,000, and S. Lawrence Feit (10) $265,000. The Company also has Excess Contribution and Excess Benefit Plans. Under such plans, the Company may establish accounting reserves and make payments directly to selected participants in the Company's Thrift and Retirement Plans, respectively, to the extent the levels of contributions or benefits for such participants under such plans are limited by sections 415, 416 and/or 401(a)(17) of the Internal Revenue Code. Such benefits commence at the time benefits commence under the related tax-qualified plan. Mr. Davidson is a participant in the Excess Benefit Plan. Messrs. Kingsberg and Feit are participants in both the Excess Contribution and Excess Benefit Plans. In 1991, the Company's Board of Directors adopted a retirement plan for the independent directors with five or more years of service at retirement and for the Chairman at the time (the "Eligible Directors"). Under the plan, Eligible Directors were entitled to receive an annual retirement benefit based on their years of service and the annual retainer at the time of retirement. On January 10, 1996, the Board of Directors terminated the plan and, as a result, the Company will distribute the current lump sum value of vested benefits to participants and beneficiaries. The lump sum value aggregated $593,381 at December 31, 1995. B. Respecting the Ratification and Approval of Appointment of Auditors by the Board of Directors Proposal (b) set forth in the accompanying Notice of Annual Meeting of Stockholders is the ratification or rejection of the action taken in the following resolutions unanimously adopted by the Board of Directors (a majority of non-interested directors voting in person) appointing the firm of Ernst & Young LLP to be the auditors of the Company for the fiscal year ending December 31, 1996. 7 "RESOLVED, that the firm of Ernst & Young LLP be and they hereby are appointed the auditors of the Company with respect to its operations for the year 1996; and further "RESOLVED, that such auditors be and they hereby are authorized and instructed to conduct an audit, in accordance with generally accepted auditing standards, of the financial statements of the Company as of and for the year ending December 31, 1996; and further "RESOLVED, that such auditors be and they hereby are authorized and instructed to conduct a review, in accordance with standards established by the American Institute of Certified Public Accountants, of the interim financial statements of the Company as of and for the six months ending June 30, 1996; and further "RESOLVED, that such appointment shall terminate (without penalty to the Company) in the event that it shall be rejected at the annual meeting of the stockholders of the Company in 1996; and further "RESOLVED, that such appointment shall terminate (without penalty to the Company) if a majority (as defined in the Investment Company Act of 1940) of the outstanding voting securities of the Company at any meeting called for the purpose shall vote to terminate such appointment; and further "RESOLVED, that the report of such auditors expressing their opinion with respect to the financial statements above described and the report of such auditors with respect to the review above described shall be addressed to the Board of Directors of the Company and to the stockholders thereof." Ernst & Young LLP were the auditors for the Company for 1995. A representative of Ernst & Young LLP will attend the Annual Meeting to respond to appropriate questions and will have the opportunity to make a statement. Stockholders who wish to submit questions in advance to the auditors may do so in writing to Mr. Stephen D. Karpf, Partner, Ernst & Young LLP, 787 Seventh Avenue, New York, N.Y. 10019. C. Shareholder Proposal Recommending that the Board Convert the Company into an Open-End Investment Company The Board of Directors has been informed by Jack N. Bonne', Horseshoe Hill Road, Pound Ridge, New York 10576, owner of 536 shares and representing an additional family interest of 3,237 shares at September 26, 1995, that he intends to submit the following proposal at the meeting: "RESOLVED, that the stockholders of General American Investors Company, Inc., assembled in annual meeting in person and by proxy, hereby request that the Board of Directors take the steps necessary to amend the Articles of Incorporation, by-laws or comply with other legal requirements to convert the fund from closed-end status to an open-end mutual fund." The Board of Directors of General American Investors unanimously recommends that you vote AGAINST this shareholder proposal relating to the conversion of the Company to an open-end investment company for the reasons set forth below. Approval of this shareholder proposal requires the affirmative vote of the holders of a majority of the shares of the Company present in person or represented by proxy at the meeting and entitled to vote. However, in the event that this shareholder proposal is approved and the Board of Directors determines to proceed with converting the Company to open-end status, it will be necessary to call another meeting of shareholders at which shareholders will be asked to vote whether or not to approve converting the Company to an open-end fund. Approval of that proposal would require the affirmative vote of two-thirds of the outstanding shares of the Company. The proponent has requested that the following statement be included in the proxy statement in support of his proposal: "Shareholders should vote in favor of this proposal to provide them with the opportunity to eliminate the large market discount, 17.8% at September 30, from the underlying net asset value of their shares and maximize the real return on their investment. On September 30 the market price of the stock was $20.875 versus the actual net asset value of $25.375 per share. 8 For the twelve months ended September 30, 1995, the market price of General American shares increased only 6.6% as compared to a 29.9% increase in Standard & Poor's 500 Index. As a result, shareholders lost the opportunity to increase the value of their investment by 23.3% if they had invested their investment in General American in an S & P 500 Index Fund. Strong support along the lines we suggest was shown at the last annual meeting when, despite strong opposition from management, almost 17% of the shareholder votes were cast in favor of this proposal. Last year your Directors stated they are concerned over the discount yet they failed to indicate what steps they have taken to reduce or eliminate the discount. On the other hand, management of other closed-end mutual funds have taken decisive action to eliminate their discount by open-ending their funds including: Paine Webbers Mitchell Hutchin's Global Income Fund, Alliance MMF, Jundt Growth Fund. Recently, Prudential Securities announced they are open- ending their Global Total Return Fund and Global Government Funds. Several other closed-end funds took actions last year to reduce the discount through large share repurchase programs including: MFS Charter Income, MFS Intermediate Income and MFS Government Income, All Seasons Global and four Putnam Family Funds. To enhance shareholder value, corporate stock buy-back programs reached record levels last year including programs by such well-known companies as Abbott Labs, Coca-Cola, Pfizer, Johnson & Johnson and Baxter International. General American shares have traded at an average discount from their net asset value in excess of 16%. Conversion of the fund shares from closed-end to open-end would eliminate this discount. Individual investors today prefer to invest in open-ended mutual funds, hence General American is at a competitive disadvantage in the mutual fund marketplace. The closed-end mutual fund analyst at Value Line stated "there may still be too many diversified domestic equity closed-end funds competing for investors' money." Conversion of General American to an open-end mutual fund would permit shareholders to monitor the actual investment performance of their fund versus being currently required to measure both market performance and portfolio performance which makes it difficult for shareholders to compare performance of their fund to others. If you agree that to best enhance the value of your shares that your Directors take the steps necessary to convert General American fund from a closed-end mutual fund to an open-end mutual fund, then please mark your proxy FOR; if disagreeing mark AGAINST. PLEASE NOTE: PROXIES NOT MARKED WILL BE VOTED AGAINST THIS RESOLUTION." Again, the Board of Directors recommends a vote AGAINST this proposal. As stated at the last annual meeting and set forth in the Company's 1995 proxy statement, your Directors are extremely concerned about the proposal to convert the Company into an open-end (mutual) fund. Their reasons for opposition to the proposal are listed below. However, the basis for their opposition rests on a fundamental view of the Company as an investment vehicle with a focus on long-term capital appreciation and a commitment to the long-term investor. The effect of changing the Company into a mutual fund would be to provide some shareholders with a quick, one-time profit at the expense of other shareholders whose interests are long-term in nature. As stated in the Company's 1995 proxy statement, the disadvantages of converting the Company to a mutual fund include: (1) Redemptions could force the sale of portfolio securities in amounts and at times disadvantageous for shareholders who did not redeem. (2) Redemptions would likely lead to forced realization of capital gains, with unfavorable tax consequences to non-redeeming shareholders. (3) Greater liquidity would have to be maintained against the possibility of continuing redemptions, thus potentially reducing overall returns. (4) The Company would be forced to make arrangements to sell new shares if it wished to offset redemptions. 9 (5) The Company would have to expend time and money to develop infrastructures to deal with the distribution, accounting, transfer agency and shareholder servicing necessary to deal with redemptions and sales of open-end funds and the resulting cash inflows and outflows. (6) As the Company is not affiliated with any broker-dealer or mutual fund sponsor, through which most mutual funds are sold, management time would be diverted to finding an underwriter and assisting in the distribution of shares. (7) The expense ratio (the ratio of operating expenses to average net assets) would probably increase as redemptions took place. (8) The Company would lose its listing on the New York Stock Exchange. Certain investors, such as pension funds, have internal restrictions on the amount of their portfolio which can be invested in non- listed securities. Conversion to an open-end fund would force the redemption of shares by shareholders subject to such restrictions. (9) The portion of the Company's assets which could be invested in smaller companies with excellent prospects but with limited marketability would be restricted. For example, under Securities and Exchange Commission interpretations, an open-end company may invest no more than 15% of its total assets in illiquid assets. (10) Uncertainty regarding the size and stability of the Company would affect the Company's ability to attract and retain capable personnel. These disadvantages are in addition to the costs of conversion itself, including the legal, accounting and printing costs. As you are aware, the key attraction for those interested in converting the Company to an open-end fund is the elimination of the discount from net asset value at which the stocks of most closed-end investment companies have traded in the market in recent years and realization of a one-time profit. Your Directors are very much aware of the discount factor. The Company's shares have traded at a discount in each of the last 20 years. They have traded at discounts of at least 10% in all but 4 of the years in that period. On the other hand, in 7 of those years (and as recently as April 1993) the shares have traded at a premium over net asset value. The Company has, over the years, devoted much effort to determining the reasons for the discount and has taken steps to alleviate it, for example, through share repurchase programs. In the past 12 months alone, the Company repurchased in excess of 1,400,000 shares of its own stock for over $28,700,000 at an average discount of 16.5%. Prior to 1995, the last time the Company's shares traded at a significant discount level was the period from 1987 to 1991. During that 5-year period, the Company repurchased over 2,500,000 shares for over $42,500,000 at an average discount of approximately 17%. In addition, your Directors believe that the underlying performance of the Company is more important than eliminating the discount. Premiums and discounts are short term indicators and are not significant to the long term investor. Meanwhile, the discount factor permits investors to purchase additional shares worth significantly more than a dollar of net assets for every dollar invested. Presumably this is a valued opportunity for General American's investors as over three-fifths of all dividends distributed in December were distributed as shares rather than cash at the shareholders' option. Another factor which must be considered is that the record for closed-end funds that have open-ended is at best mixed.* For example, the Japan Fund, which open-ended in August 1987 has experienced an increased expense ratio. Similarly, the Alliance New Europe Fund, which open-ended in March 1991, has experienced a substantial drop in its asset base as well as an increase in expense ratio. More recently, during the first two months following the mergers of ACM Managed Multi-Market Trust** (May 1995) and the - -------- * See, Catherine Gillis, "Where are They Now?" Following up on funds that have open-ended, merged or liquidated. Morningstar, Closed-End Funds, August 12, 1994, pp. S1-S2. ** ACM Managed Multi-Market Trust is now Alliance Multi-Market Strategy Trust Inc. and the Global Privatization Fund is now Alliance Worldwide Privatization Fund Inc. 10 Global Privatization Fund (October 1995) into open-end funds, redemptions amounted to 20% - 30% of the net assets of each of these funds. For these reasons, the fact that the Company's stock is trading at a discount is not a basis for converting the Company into a mutual fund. Proposals to effect similar structural changes, have been made to the managements of other closed-end investment companies. The shareholders of many of these companies have voted against such proposals. For example, in October 1994, 4 funds advised by Massachusetts Financial Services, each defeated shareholder proposals similar to the proposal included in this Proxy Statement. Since that time, the shareholders of each of Tri-Continental Corporation (May 1995), R.O.C. Taiwan Fund (July 1995), United Kingdom Fund (September 1995), Putnam Intermediate Government Fund (October 1995) and MFS Charter Income Trust (October 1995) have voted against similar proposals. As you know, when the same proposal was put before the Company's shareholders at the 1995 annual meeting, 83% of the shares voted were cast against this proposal. Your Directors believe that there is an important continuing service to be provided to the investing public by General American Investors as a medium-sized closed-end investment fund. Your negative vote for the proposal to convert the Company from closed-end status to open-end mutual fund status will help to assure its continuity as a closed-end fund in the long-term interests of all its shareholders. D. Respecting Other Matters Which May Come Before the Meeting The Board of Directors of the Company does not know of any other matters which may come before the meeting. However, if any other matters, of which the Board of Directors is not now aware, are properly presented for action before the meeting, including any questions as to the adjournment of the meeting, it is the intention of the persons named in the accompanying form of proxy to vote such proxy in accordance with their judgment on such matters. E. Allocation of Portfolio Brokerage Brokerage commissions paid by the Company during 1995 were $609,368, including $124,075 (20.36%) paid to Goldman, Sachs & Co. During the period January 1, through May 10, 1995, a director of the Company was a limited partner of The Goldman Sachs Group, L.P. which is an affiliate of Goldman, Sachs & Co. Of the aggregate dollar amount of the Company's transactions involving brokerage commissions during 1995, 18.29% were effected through Goldman, Sachs & Co. The Company's general policy regarding the execution of securities transactions is to select brokers and dealers on the basis of the most favorable markets, prices and execution of orders. A certain amount of the Company's securities transactions are placed with brokers and dealers who provide brokerage and research services and in these circumstances the commissions paid may be higher than those which might otherwise have been paid to another broker or dealer if those services had not been provided. Research services generally include receipt of written reports, attendance at meetings or participation in discussions with respect to specific subjects, such as a company, an industry or the economic outlook. Block availability is also a consideration in determining the selection of brokers. The Company and, if applicable, the Company's subsidiary seek to utilize services obtained from brokers and dealers fairly with respect to all accounts under their management. To the extent that the ability to direct brokerage enhances their access to such services, the benefits are fairly shared. In negotiating brokerage commissions on securities transactions, the Company's trader with his awareness of competitive rates negotiates the most favorable commission to effect a particular transaction. Size of order and difficulty of execution are considerations in the negotiation. All transactions, including the commission factor, are subject to supervision and review by the Company's officers. F. Portfolio Turnover Rate The annual rate of the total portfolio turnover for the fiscal year ended December 31, 1995 was 29.14%. 11 G. Stockholder Proposals In order for a stockholder proposal to be considered for inclusion in the Company's proxy material relating to its 1997 annual meeting of stockholders, the stockholder proposal must be received by the Company no later than October 8, 1996, and must comply with certain other rules and regulations promulgated by the Securities and Exchange Commission. - ------------------------------------------------------------------------------- The expense of the solicitation of proxies for this meeting will be borne by the Company. In addition to mailing copies of this material to stockholders, the Company will request persons who hold stock for others, in their names or custody or in the names of nominees, to forward copies of such material to those persons for whom they hold stock of the Company and to request authority for the execution of the proxies. The Company may reimburse such persons for their out-of-pocket expenses incurred in connection therewith. Chemical Mellon Shareholder Services, L.L.C. has been retained to assist in the solicitation of proxies at a fee to be paid by the Company and estimated at $6,500, plus disbursements. It is important that proxies be returned promptly. Therefore, stockholders who do not expect to attend in person and who wish their stock to be voted are urged to fill in, sign and return the accompanying form of proxy in the enclosed envelope. GENERAL AMERICAN INVESTORS COMPANY, INC. 450 Lexington Avenue New York, NY 10017 THIS PROXY IS BEING SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoints Lawrence B. Buttenwieser, Spencer Davidson and Victoria Hamilton as Proxies, each with the power to appoint his substitute, and hereby authorizes each of them to represent and to vote, as designated below, all stock of the above Company which the undersigned is entitled to vote, at the annual meeting of stockholders on March 13, 1996, and at any adjournment thereof. The shares represented by this proxy will be voted as directed by the shareholder. If no direction is given when the duly executed proxy is returned, such shares will be voted "FOR all nominees" in item A, "FOR" item B and "AGAINST" item C. Please mark your votes as indicated in this example [X] The Board of Directors recommends a vote "FOR ALL NOMINEES" in item A, "FOR" item "B" and "AGAINST" item C. A. Election of the following nominees as Directors: Mr. Altschul, Mr. Buttenwieser, Mr. Cullman, Mr. Davidson, Dr. Edelman, Mr. Frank, Mr. Gordan, Mr. Green, Ms. Hamilton, Mr. Knafel, Mr. Pivirotto, Mr. Smith, Mr. Stewart and Mr. Troubh [ ] FOR all nominees except any indicated [ ] WITHHOLD AUTHORITY to vote for all listed nominees (Instruction: To withhold authority to vote for individual nominees, write the nominees' names on the line below) _________________________________________________________________________ B. Ratification of Ernst & Young LLP as auditors. [ ] FOR [ ] AGAINST [ ] ABSTAIN C. Approval of the shareholder proposal relating to the conversion of the Company into an open-end investment company. [ ] FOR [ ] AGAINST [ ] ABSTAIN D. In their discretion, the appointees are authorized to vote upon any other matters which may properly come before the meeting or any adjournments thereof. Signature(s)__________________________________________ Date______________________ Please date and sign your name as it appears above and return in the enclosed envelope. When signing as an attorney, executor, administrator, trustee, or guardian, please give title as such. If a signer is a corporation, please sign full corporate name by authorized officer and attach corporate seal. For joint accounts, each joint owner should sign. -----END PRIVACY-ENHANCED MESSAGE-----